Yahoo Finance Insider Sale: National Group President Bradley Owens Sells Shares of Surgery Partners Inc (SGRY)
Bradley Owens, National Group President of Surgery Partners Inc (NASDAQ:SGRY), executed a sale of 6,000 shares in the company on May 31, 2024. The transaction was filed on the same day through an SEC Filing. Following this transaction, the insider now owns 72,338 shares of the company.
Over the past year, Bradley Owens has sold a total of 12,113 shares of Surgery Partners Inc and has not made any purchases of the stock. This recent transaction continues a trend observed over the last year, where there have been 33 insider sells and no insider buys.
Surgery Partners Inc, a healthcare services company, operates surgical facilities that include ambulatory surgery centers and surgical hospitals. Its services cater to patients requiring non-emergency surgical procedures across various specialties.
On the date of the latest transaction, shares of Surgery Partners Inc were priced at $27.65. The company has a market cap of approximately $3.37 billion. The price-earnings ratio stands at 9,999.00, significantly above both the industry median of 24.86 and the company's historical median.
According to the GF Value, the intrinsic value of Surgery Partners Inc is estimated at $29.60 per share, making the stock modestly undervalued with a price-to-GF-Value ratio of 0.93.
The GF Value is calculated based on historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted for the company's past performance and estimated future business outcomes.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
